Martindale Pharma - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move

Boliden AB (STO: BOL) warns Garpenberg seismic damage will cut 2026 output and hit Q1 EBITDA

Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?

Representative image of a motorway corridor and capital flows illustrating HICL Infrastructure PLC’s £311 million A63 Motorway stake sale in France, as the London-listed infrastructure investor exits the Atlandes asset at a 21% premium to book value.

HICL Infrastructure (LSE: HICL) to sell A63 Motorway stake for £311m at 21% premium to book value

Read More

5 minute read

Pharma Industry News

Martindale Pharma gains regulatory approval for pediatric clobazam oral suspension in seven European countries

Martindale Pharma’s clobazam liquid suspension gains approval in 7 EU countries, improving pediatric epilepsy care with licensed dosing alternatives.

bypharmanewsdaily

October 25, 2016

web analytics